Mild to moderate preoperative patellar tendinopathy may not significantly affect postoperative outcomes of ACL ...

A novel synthetic bone graft utilizing submicron-sized needle-shaped surface biphasic calcium phosphate may be superior to ...

SurGenTec announced that OsteoFlo HydroFiber, its synthetic bone graft solution equivalent to autograft, is now being used in ...

The global bone grafts & substitutes market was valued at $2,652.6 million in 2020, and is projected to reach $3,362.6 million by 2028, registering a CAGR of 4.3% from 2021 to 2028. Rise in incidences ...

Traditional bone-patellar tendon-bone and hamstring tendon ACL grafts are not without limitations. A growing body of anatomic, biomechanical and clinical data has demonstrated the utility of ...

Bone grafts can be either taken from the patient’s own body (an autograft), from a donor’s body (allograft) or are engineered (ie a synthetic material). An autograft introduces the patient’s own ...

By removing the need for autograft harvesting ... “This product is set to revolutionise bone graft technology. “OsteoFlo HydroFiber provides a novel, customisable solution for surgeons ...

This systematic review has demonstrated excellent clinical outcomes (pain, strength, motion, and stability) after surgical treatment (repair and autograft reconstruction) of both acute and chronic ...

a stabilization and removal of bone is used called a Burton and Pellegrini procedure. This is discussed as the modern LRTI. It is a partial thickness flexor carpi radialis tendon autograft which ...